openPR Logo
Press release

Orthobiologics Market Size, Growth, Opportunities 2024-2032 | Medtronic, Zimmer Biomet, DePuy Synthes (Johnson & Johnson Services, Inc.), Stryker, Anika Therapeutics, Inc

11-08-2024 08:55 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Orthobiologics Market

Orthobiologics Market

The orthobiologics market centers on biologically-derived treatments that promote healing and tissue regeneration in orthopedic and musculoskeletal conditions. Orthobiologics include treatments such as bone grafts, stem cell therapies, platelet-rich plasma (PRP), and hyaluronic acid injections, used to repair or replace damaged tissues, bones, and cartilage in injuries and degenerative conditions like osteoarthritis. With the increased focus on minimally invasive procedures, orthobiologics are becoming a preferred alternative to more extensive surgeries, offering faster recovery times and natural healing processes by leveraging the body's regenerative capabilities.

๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ ๐—ช๐—ต๐—ฎ๐˜ ๐—ฌ๐—ผ๐˜‚'๐—ฟ๐—ฒ ๐— ๐—ถ๐˜€๐˜€๐—ถ๐—ป๐—ด: ๐—š๐—ฒ๐˜ ๐—ฎ ๐—™๐—ฟ๐—ฒ๐—ฒ ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ (๐—ฃ๐——๐—™) ๐—ฆ๐—ฎ๐—บ๐—ฝ๐—น๐—ฒ: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthobiologics-market-100173

๐—ž๐—ฒ๐˜† ๐—œ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜† ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ :

In October 2023, Orthofix Medical Inc. announced the full commercial launch and received 510(k) clearance for OsteoCove, an advanced bioactive synthetic graft designed for use in various orthopedic and spinal procedures.

๐—ง๐—ผ๐—ฝ ๐—ฐ๐—ผ๐—บ๐—ฝ๐—ฎ๐—ป๐—ถ๐—ฒ๐˜€ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—ข๐—ฟ๐˜๐—ต๐—ผ๐—ฏ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐˜€ ๐— ๐—ฎ๐—ฟ๐—ธ๐—ฒ๐˜:

โ€ข Medtronic (Ireland)
โ€ข Zimmer Biomet (US)
โ€ข DePuy Synthes (Johnson & Johnson Services, Inc.) (US)
โ€ข Stryker (US)
โ€ข Anika Therapeutics, Inc. (US)
โ€ข SeaSpine (US)
โ€ข Bioventus (US)
โ€ข RTI Surgical (US)

๐—ฆ๐—ฒ๐—ด๐—บ๐—ฒ๐—ป๐˜๐˜€ :

The orthobiologics market is segmented by product types, applications, and end users. Product segments include demineralized bone matrices, synthetic bone substitutes, bone marrow aspirate concentrate, hyaluronic acid, and stem cell-based therapies, each addressing specific treatment needs across orthopedic care. Applications for orthobiologics span spinal fusion, joint reconstruction, fracture repair, and sports medicine, where the regenerative properties of these biologics support tissue repair and accelerate recovery. End users include hospitals, orthopedic clinics, and specialized surgical centers that implement orthobiologic solutions for a variety of musculoskeletal injuries and degenerative conditions. As advancements in biotechnology progress, these segments offer targeted solutions that enable more personalized and effective care in orthopedics.

๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ :

The report has studied the market in depth and underlined several crucial aspects and leading market participants. It provides important insights into the recent market trends and key industry developments. In addition to the factors mentioned above, the report covers many other factors that have helped the market grow.

๐—™๐—ผ๐—ฟ ๐—™๐˜‚๐—น๐—น ๐—ฅ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—–๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐—ฎ๐—ด๐—ฒ ๐—ฉ๐—ถ๐˜€๐—ถ๐˜ : https://www.fortunebusinessinsights.com/industry-reports/orthobiologics-market-100173

๐——๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฅ๐—ฒ๐˜€๐˜๐—ฟ๐—ฎ๐—ถ๐—ป๐˜๐˜€ :

The orthobiologics market is driven by several factors, primarily the growing demand for minimally invasive procedures and a rising prevalence of musculoskeletal disorders, such as osteoarthritis and spinal injuries. Patients and healthcare providers increasingly prefer biologically-based treatments that enable faster recovery and natural healing, avoiding the risks and extended recovery associated with traditional surgeries. Additionally, advancements in biotechnology, including stem cell research and tissue engineering, have fueled the development of innovative orthobiologic products like bioactive bone grafts and platelet-rich plasma, enhancing the market's appeal and accessibility. The aging global population further supports market growth, as older adults commonly experience degenerative joint and bone conditions that benefit from orthobiologics solutions.

However, several restraints affect the orthobiologics market's growth. One of the primary challenges is the high cost of orthobiologics treatments, which are often not fully covered by insurance, limiting patient access. Regulatory hurdles also pose barriers, as stringent approval processes are required for biologically-derived products to ensure their safety and efficacy. This regulatory complexity can slow the introduction of new products into the market. Additionally, limited awareness and availability of orthobiologics in emerging markets hinder adoption in regions where healthcare systems are still developing. Despite these restraints, the orthobiologics market is expected to expand as technological and regulatory advancements improve accessibility and affordability.

๐—ฅ๐—ฒ๐—ด๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€ :

North America Dominated Market Due to Growing Use of Biologics for Bone-Related Disorders

North America dominated the global market in 2022 as the region is rapidly adopting biologic products for several bone-related disorders and injuries. Moreover, many key market players in North America are introducing novel synthetic products to improve patient care and fasten the bone healing process, which will further boost the regional market growth.

Europe captured the second-largest market share in 2022 and might record a strong CAGR during the forecast period due to the introduction of favorable health reimbursement policies for bone graft procedures.

๐—–๐—ผ๐—บ๐—ฝ๐—ฒ๐˜๐—ถ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—Ÿ๐—ฎ๐—ป๐—ฑ๐˜€๐—ฐ๐—ฎ๐—ฝ๐—ฒ :

Leading Market Players to Dominate the Market With Their Strong Product Portfolios

The market's competitive landscape is highly fragmented, with Medtronic capturing the largest market share in 2022 as it has a vast portfolio of bone graft substitutes. The company is also increasing its focus on expanding its geographical presence by introducing novel orthobiologic products. The other key market players include Stryker Corporation, SeaSpine Holdings Corporation, Anika Therapeutics, Inc., Globus Medical, Integra LifeSciences, and Bioventus.

Meanwhile, a growing number of smaller companies and startups are emerging, especially in North America and Europe, contributing to a dynamic competitive landscape. These firms often focus on specific niches within orthobiologics, such as tissue engineering or bone regeneration, bringing cutting-edge innovations and targeting unmet needs in orthopedic treatments. Companies like Orthofix Medical and AlloSource are examples of firms that have carved out unique spaces within the market, emphasizing new product developments and strategic alliances. As the market grows, competition is expected to intensify, with key players vying for market share through product differentiation, clinical trials, and geographical expansion, while navigating regulatory and reimbursement challenges across regions.

๐—–๐˜‚๐˜€๐˜๐—ผ๐—บ๐—ถ๐˜‡๐—ฒ ๐˜๐—ต๐—ถ๐˜€ ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜ ๐—ฎ๐—ฐ๐—ฐ๐—ผ๐—ฟ๐—ฑ๐—ถ๐—ป๐—ด ๐˜๐—ผ ๐˜†๐—ผ๐˜‚๐—ฟ ๐—ฐ๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ป๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ : https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/orthobiologics-market-100173

Contact Us:
Fortune Business Insightsโ„ข Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

Fortune Business Insightsโ„ข offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Orthobiologics Market Size, Growth, Opportunities 2024-2032 | Medtronic, Zimmer Biomet, DePuy Synthes (Johnson & Johnson Services, Inc.), Stryker, Anika Therapeutics, Inc here

News-ID: 3724784 • Views: โ€ฆ

More Releases from Fortune Business Insights

U.S. Medical Tourism Market Size, Trends, Growth, Opportunities (2023-2030) | Cleveland Clinic, Mayo Foundation for Medical Education and Research and The General Hospital Corp
U.S. Medical Tourism Market Size, Trends, Growth, Opportunities (2023-2030) | Cl โ€ฆ
The U.S. medical tourism market size was worth USD 4.58 billion in 2022 and is projected to grow at a CAGR of 21.0% during the forecast period (2023-2030). Medical tourism, also called medical travel, can be defined as travel across international borders of the global population seeking medical or wellness treatment across healthcare settings. The adoption of medical tourism across developing countries is high owing to the low cost of serviceโ€ฆ
Postpartum Depression Treatment Market Size, Trends, Growth, Opportunities (2024-2032) | Sage Therapeutics, Inc. and Biogen, Inc.
Postpartum Depression Treatment Market Size, Trends, Growth, Opportunities (2024 โ€ฆ
The postpartum depression treatment market size was valued at USD 12.2 million in 2023 and is projected to grow from USD 79.9 million in 2024 to USD 973.0 million by 2032, recording a CAGR of 36.7% during the forecast period (2023-2030). Postpartum depression (PPD) is a medical condition that occurs sometimes during pregnancy or in the first year after giving birth. This medical condition is also known as peripartum depression. Itโ€ฆ
Microdermabrasion Devices Market Size, Trends, Growth, Opportunities (2023-2030) | Age Sciences Inc., ImageDerm Inc., and Koninklijke Philips N.V.
Microdermabrasion Devices Market Size, Trends, Growth, Opportunities (2023-2030) โ€ฆ
The microdermabrasion devices market size was valued at USD 507.4 million in 2022 and is projected to grow from USD 583.0 million in 2023 to USD 1,057.5 million by 2030, recording a CAGR of 8.9% during the forecast period (2023-2030). The Microdermabrasion Devices Market is gaining traction as advanced skincare devices become more accessible to consumers and professionals. Offering effective solutions for exfoliation, rejuvenation, and skin care, microdermabrasion devices are revolutionizingโ€ฆ
Para Aminophenol Market is Poised for growth from USD 657.3 million in 2024 to USD 1,052.9 million by 2032, exhibiting a CAGR of 6.1%
Para Aminophenol Market is Poised for growth from USD 657.3 million in 2024 to U โ€ฆ
The Para Aminophenol (PAP) market plays a critical role in several industries, including pharmaceuticals, dyes, and rubber manufacturing. Para Aminophenol, a versatile organic compound, is primarily used as a key intermediate in the production of paracetamol (acetaminophen), one of the most widely used analgesics and antipyretics globally. Additionally, its applications in hair dyes and photographic chemicals contribute to the market's demand. Market Overview The global para aminophenol market was valued at USDโ€ฆ

All 5 Releases


More Releases for Orthobiologics

Orthobiologics Market Objectives and Detailed Study 2018
WiseGuyReports.Com Publish a New Market Research Report On โ€“โ€œ Orthobiologics Market Objectives and Detailed Study 2018โ€. Description:- The Orthobiologics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Orthobiologics market size to maintain the average annual growth rate of 3.04% from 4260 million $ in 2014 to 4660 million $ in 2017, The analysts believe that in the next few years, Orthobiologicsโ€ฆ
Global Orthobiologics Market Analysis & Overview 2022
Qyresearchreports include new market research report "Global Orthobiologics Market Size, Status and Forecast 2022" to its huge collection of research reports. The report on the global market for Orthobiologics tries to help stakeholders in acquiring a 360-degree knowledge of the prevalent trends and pitfalls in the market. It is a repository of crucial information that can help companies in their important decision making procedures. The report examines the various growth driversโ€ฆ
Global Orthobiologics Market $6.2 Billion by 2021
Orthobiologics Market Analysis and Forecast 2017-2021 report estimates the global orthobiologics market to reach nearly $6.2 Billion in 2021, at a CAGR of 6.2% from 2017 to 2021 - iHealthcareAnalyst, Inc. The global orthobiologics market report provides market size (Revenue $Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021). The global orthobiologics market segmentation is based on product types (allograft, bone morphogenetic proteins, demineralized bone matrix,โ€ฆ
Orthobiologics Market Intelligence Report for Comprehensive Information
Biologic treatment has made a significant impact in orthopedic surgery, incorporating patientโ€™s own cells, tissues, proteins produced artificially, etc. in the orthopedic treatment. The demand for global orthobiologics market is increasing due to the rise in aging population, changing lifestyles, problems associated with musculoskeletal system and developments in technologies. The global orthobiologics market is anticipated to grow with double digit growth rate over the forecast period with the demand forโ€ฆ
Global Orthobiologics Sales Market Report 2017
In this report, the global Orthobiologics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report studies Orthobiologics in Global Sales market , especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with sales, price, revenue and marketโ€ฆ
Orthobiologics Market USD 5.8 Billion by 2020
Orthobiologics Market 2013-2020 report estimates the global orthobiologics market to reach nearly USD 5.8 Billion in 2020, at a CAGR of 6.2% from 2016 to 2020 - iHealthcareAnalyst, Inc. Visit the Orthobiologics Market 2013-2020 report https://www.ihealthcareanalyst.com/report/orthobiologics-market/ The global orthobiologics market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020). The global orthobiologics market segmentation is based on product types (allograft, boneโ€ฆ